## Consolidated Statement of Equity

**Year Ended**

|  | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 |
| --- | --- | --- | --- |
|       Total Stockholders' Equity - Beginning balance | 141,988 | 118,304 | 118,304 |
| *        Common stock and paid-in capital* | 86,939 | 83,111 | 80,552 |
| *        Retained earnings* | 84,281 | 57,055 | 34,566 |
| *        Accumulated other comprehensive income (loss)* | (4,678) | 1,822 | 3,186 |
| *        Derivatives* | (13) | (19) | (38) |
| *        Investments* | (2,138) | 3,222 | 5,478 |
| *        Translation adjustments and other* | (2,527) | (1,381) | (2,254) |
| *        Cumulative effect of accounting changes - Retained earnings* |  |  | (32) |
| *        Cumulative effect of accounting changes - Accumulated other comprehensive income (loss)* |  |  | 10 |
| *        Cumulative effect of accounting changes - Investments* |  |  | 10 |
|       Accounting Standards Update [Extensible List] | http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201601Member | http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201601Member | http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201601Member |
|       Common stock issued - Beginning balance |  |  |  |
| *        Common stock and paid-in capital - Ending balance* | 1,841 | 1,963 | 1,343 |
|       Net Income - Beginning balance | 72,738 | 61,271 | 44,281 |
| *        Retained earnings - Ending balance* | 72,738 | 61,271 | 44,281 |
|       Other comprehensive income (loss) - Beginning balance | (6,500) | (1,374) | 3,526 |
| *        Accumulated other comprehensive income (loss)* | (6,500) | (1,374) | 3,526 |
| *        Derivatives* | 6 | 19 | (38) |
| *        Investments* | (5,360) | (2,266) | 3,990 |
| *        Translation adjustments and other - Ending balance* | (1,146) | 873 | (426) |
|       Common stock cash dividends - Beginning balance | 18,556 | 16,871 |  |
| *        Retained earnings - Ending balance* | 18,552 | 16,871 | 15,483 |
|       Common stock repurchased - Beginning balance |  |  |  |
| *        Common stock and paid-in capital* | 5,688 | 5,539 | 4,599 |
| *        Retained earnings* | 26,960 | 21,879 | 18,382 |
| *        Share Repurchase Program 2021* | 28,033 |  |  |
| *        Share Repurchase Program 2019* |  | 22,970 |  |
| *        Share Repurchase Program 2016* |  |  | 19,688 |
| *        Share Repurchase Program 2019 and 2021* |  |  |  |
| *        Share Repurchase Programs 2016 and 2019 - Ending balance* |  |  |  |
|       Stock-based compensation expense - Beginning balance |  |  |  |
| *        Common stock and paid-in capital - Ending balance* | 7,502 | 6,118 | 5,289 |
|       Other, net - Beginning balance |  |  |  |
| *        Common stock and paid-in capital - Ending balance* | (173) | (17) | 1 |
|       Total Stockholders' Equity | 166,542 | 141,988 | 118,304 |
| *        Common stock and paid-in capital* | 86,939 | 83,111 | 80,552 |
| *        Retained earnings* | 84,281 | 57,055 | 34,566 |
| *        Accumulated other comprehensive income (loss)* | (4,678) | 1,822 | 3,186 |
| *        Derivatives* | (13) | (19) | (38) |
| *        Investments* | (2,138) | 3,222 | 5,478 |
| *        Translation adjustments and other* | (2,527) | (1,381) | (2,254) |
| *        Cumulative effect of accounting changes - Retained earnings* |  |  | (32) |
| *        Cumulative effect of accounting changes - Accumulated other comprehensive income (loss)* |  |  | 10 |
| *        Cumulative effect of accounting changes - Investments - Ending balance* |  |  | 10 |
|       Cash dividends declared per common share | 2.48 | 2.24 | 2.04 |